Yaz

DRUG2 trials

Sponsors

Saitama Medical University, St. Joseph's Healthcare Hamilton

Conditions

Bipolar DisorderPremenstrual Dysphoric Disorderadenomyosis

Phase 2

Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

CompletedNCT05098574

St. Joseph's Healthcare HamiltonBipolar Disorder, Premenstrual Dysphoric Disorder

Start: 2023-02-03End: 2024-04-11Updated: 2024-09-23

Unknown Phase

The investigation effectiveness of YAZ for dysmenorrhea associated with adenomyosis

Active, not recruitingJPRN-UMIN000015432

Saitama Medical Universityadenomyosis

Start: 2014-11-01Target: 25Updated: 2026-06-29